Regeneron Pharmaceuticals Inc (REGN)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $98.84B
Last updated: Nov 17, 2026 at 4:34 PM ET
Regeneron Pharmaceuticals Inc (REGN) Stock Chart
Regeneron Pharmaceuticals (REGN) has a latest price of $957.76 on Nov 17, 2026, 3.4% below its 52-week high of $991.73. Its price rose 38.4% over the past 12 months. The month-end price rose 168.9% over the 10 years through Oct 2026, a compound annual rate of 10.4%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $1,184.69 in Aug 2024 and its lowest $277.40 in Sep 2019, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart REGN with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for REGN.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price rose 13.9%, and over 6 months it rose 52.3%. The month-end price rose 19.0% over the 3 years through Oct 2026, a compound annual rate of 6.0%.
| Period | Change |
|---|---|
| 1 month | +22.5% |
| 3 months | +13.9% |
| 6 months | +52.3% |
| 12 months | +38.4% |
| 12 months, with dividends | +39.0% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +19.0% | +6.0% |
| 5 years | +45.0% | +7.7% |
| 10 years | +168.9% | +10.4% |
Price by Year
Its best calendar year was 2021, when the price rose 30.7%, and its weakest was 2024, when it fell 18.9%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $927.89 | +20.2% |
| 2025 | $771.87 | +8.4% |
| 2024 | $712.33 | -18.9% |
| 2023 | $878.29 | +21.7% |
| 2022 | $721.49 | +14.2% |
| 2021 | $631.52 | +30.7% |
| 2020 | $483.11 | +28.7% |
| 2019 | $375.48 | +0.5% |
| 2018 | $373.50 | -0.7% |
| 2017 | $375.96 | +2.4% |
Trading Range
The price is 16.6% above its 50-day average of $821.61 and 28.0% above its 200-day average of $748.12.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $957.76 | |
| 52-week high | $991.73 | -3.4% |
| 52-week low | $590.83 | +62.1% |
| 50-day average | $821.61 | +16.6% |
| 200-day average | $748.12 | +28.0% |
Price Risk
Over 3 years, its largest fall from a peak was 59.7%.
| Measure | Value |
|---|---|
| 1-year beta | 0.38 |
| Largest fall, 1 year | -25.9% |
| Largest fall, 3 years | -59.7% |
Valuation
Regeneron Pharmaceuticals traded at 17.4x earnings at the end of 2025, against a 5-year median of 16.4x and a 10-year median of 16.9x.
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About REGN
What is REGN's 1-year price change?
Regeneron Pharmaceuticals's price rose 38.4% over the past 12 months. With dividends included, the 12-month total return was 39.0%.
What is REGN's 5-year price change?
Regeneron Pharmaceuticals's month-end price rose 45.0% over the 5 years through Oct 2026, a compound annual rate of 7.7%. These figures leave out dividends.
What is REGN's 52-week high and low?
Regeneron Pharmaceuticals's 52-week high is $991.73 and its 52-week low is $590.83. Its latest price of $957.76 on Nov 17, 2026 is 3.4% below the high.
What is REGN's beta?
Regeneron Pharmaceuticals's 1-year beta against the S&P 500 is 0.38, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 25.9%.
Is the REGN chart free?
Yes. Advanced Charting for REGN is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
REGN pages: Overview, Dividends, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts